Clinuvel Pharmaceuticals Ltd所有资讯

Clinuvel Pharmaceuticals Ltd：主席致辞

10/16 06:13

Clinuvel Pharmaceuticals Ltd：加拿大在EPP中提交了SCENESSE的新药申请

10/01 06:23

Clinuvel Pharmaceuticals Ltd：SCENESSE数据将在全球卟啉病会议上公布

09/20 06:22

Clinuvel Pharmaceuticals Ltd：股东周年大会会议时间变更

09/13 07:24

Clinuvel Pharmaceuticals Ltd：董事的首次利息通知-Pearl Grimes

09/10 13:22

Clinuvel Pharmaceuticals Ltd：董事的初步利息通知-Guy van Dievoet

09/10 13:22

Clinuvel Pharmaceuticals Ltd：董事的初步利息通知——马修·普林格尔

09/10 13:21

Clinuvel Pharmaceuticals Ltd：CLINUVEL 投资者网络研讨会

08/30 07:48

Clinuvel Pharmaceuticals Ltd：公司治理声明

08/29 07:33

Clinuvel Pharmaceuticals Ltd：附录 4G

08/29 07:32

Clinuvel Pharmaceuticals Ltd：股息/分配-CUV

08/29 07:30

Clinuvel Pharmaceuticals Ltd：白癜风和业务更新

08/21 07:12

Clinuvel Pharmaceuticals Ltd：年度业绩网络研讨会

08/19 07:35

Clinuvel Pharmaceuticals Ltd：阿法诺肽协助紫外线损伤后的DNA修复反应

07/05 07:40

Clinuvel Pharmaceuticals Ltd：SCENESSE获得了欧洲治疗孤儿药物认定

06/24 06:57

Clinuvel Pharmaceuticals Ltd：对于皮肤较浅的帕金森患者，afamelanotide是一种有效的治疗方法。

06/18 07:27

Clinuvel Pharmaceuticals Ltd：CLINUVEL通讯 III - 2024年6月

06/11 07:52

Clinuvel Pharmaceuticals Ltd：CLINUVEL 取消了对青少年 EPP 的标签扩展

06/03 07:01

Clinuvel Pharmaceuticals Ltd：CLINUVEL 和 Valentech 进入拉丁美洲合作伙伴关系

05/23 07:57

Clinuvel Pharmaceuticals Ltd：SCENESSE XP 欧洲孤儿药认定

04/29 07:24